李明家副教授研究團隊發表研究成果於Biomacromolecules

連結網址：https://pubs.acs.org/doi/10.1021/acs.biomac.3c00522

Abstract

Taking inspiration from spider silk protein spinning, we developed a method to produce tough filaments using extrusion-based 3D bioprinting and salting-out of the protein. To enhance both stiffness and ductility, we have designed a blend of partially crystalline, thermally sensitive natural polymer gelatin and viscoelastic G-polymer networks, mimicking the components of spider silk. Additionally, we have incorporated inorganic nanoparticles as a rheological modifier to fine-tune the 3D printing properties. This self-healing nanocomposite hydrogel exhibits exceptional mechanical properties, biocompatibility, shear thinning behavior, and a well-controlled gelation mechanism for 3D printing.

趙瑞益教授研究團隊發表研究成果於ACS Nano

連結網址：https://pubmed.ncbi.nlm.nih.gov/37737568/

Abstract

Selective autophagy is a defense mechanism by which foreign pathogens and abnormal substances are processed to maintain cellular homeostasis. Sequestosome 1 (SQSTM1)/p62, a vital selective autophagy receptor, recruits ubiquitinated cargo to form autophagosomes for lysosomal degradation. Nab-PTX is an albumin-bound paclitaxel nanoparticle used in clinical cancer therapy. However, the role of SQSTM1 in regulating the delivery and efficacy of nanodrugs remains unclear. Here we showed that SQSTM1 plays a crucial role in Nab-PTX drug delivery and efficacy in human lung and colorectal cancers. Nab-PTX induces SQSTM1 phosphorylation at Ser403, which facilitates its incorporation into the selective autophagy of nanoparticles, known as nanoparticulophagy. Nab-PTX increased LC3-II protein expression, which triggered autophagosome formation. SQSTM1 enhanced Nab-PTX recognition to form autophagosomes, which were delivered to lysosomes for albumin degradation, thereby releasing PTX to induce mitotic catastrophe and apoptosis. Knockout of SQSTM1 downregulated Nab-PTX-induced mitotic catastrophe, apoptosis, and tumor inhibition in vitro and in vivo and inhibited Nab-PTX-induced caspase 3 activation via a p53-independent pathway. Ectopic expression of SQSTM1 by transfection of an SQSTM1-GFP vector restored the drug efficacy of Nab-PTX. Importantly, SQSTM1 is highly expressed in advanced lung and colorectal tumors and is associated with poor overall survival in clinical patients. Targeting SQSTM1 may provide an important strategy to improve nanodrug efficacy in clinical cancer therapy. This study demonstrates the enhanced efficacy of Nab-PTX for human lung and colorectal cancers via SQSTM1-mediated nanodrug delivery.

李明家副教授研究團隊發表研究成果於JACS Au，並獲選該期刊封面故事。

連結網址：https://pubs.acs.org/doi/10.1021/jacsau.3c00390

Abstract

Circularly polarized luminescence (CPL) is typically achieved with a chiral luminophore. However, using a helical nanosized fused quartz cell consisting of chiral silica, we could control the wavelength and helical sense of the CPL of an achiral luminophore. Chiral silica with a helical nanostructure was prepared by calcining a mixture of polyhedral oligomeric silsesquioxane (POSS)-functionalized isotactic poly(methacrylate) (it-PMAPOSS) and a small amount of chiral dopant. The chiral silica encapsulated functional molecules, including luminophores, along the helical nanocavity, leading to induced circular dichroism (ICD) and induced circularly polarized luminescence (iCPL). Because chiral silica can act as a helical nanosized fused quartz cell, it can encapsulate not only the luminophore but also solvent molecules. By changing the solvent in the luminophore-containing nanosized fused quartz cell, the wavelength of the CPL was controlled. This method provides an effective strategy for designing novel CPL-active materials.